A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 180 participants.
Also called NCT02368665
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT02368665
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02368665. Randomized; quadruple masking; primary purpose treatment. Start 2014-12 (actual); primary completion 2015-11 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Efficacy and Safety of Amlodipine Besylate and Candesartan Cilexetil in Essential Hypertension Patient Who Are Not Adequately Controlled With Amlodipine Besylate Monotherapy
- Condition
- Essential Hypertension
- Intervention (Drug)
- Amlodipine 5mg
- Intervention (Drug)
- Amlodipine 5mg, Candesartan cilexetil 16mg
- Intervention (Drug)
- Amlodipine 10mg, Candesartan cilexetil 16mg
- Lead sponsor
- HK inno.N Corporation
Record details
- Record id
cardio:ct-nct02368665- Content hash
4bb314b9dd383656555b09fffb33235caab698a14cf5e9b2881441aab07f22f0